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Abstract
PTPN3 and PTPN4 are two closely-related non-receptor protein tyrosine phosphatases (PTP) that, in addition to a PTP
domain, contain FERM (Band 4.1, Ezrin, Radixin, and Moesin) and PDZ (PSD-95, Dlg, ZO-1) domains. Both PTP have been
implicated as negative-regulators of early signal transduction through the T cell antigen receptor (TCR), acting to
dephosphorylate the TCRf chain, a component of the TCR complex. Previously, we reported upon the production and
characterization of PTPN3-deficient mice which show normal TCR signal transduction and T cell function. To address if the
lack of a T cell phenotype in PTPN3-deficient mice can be explained by functional redundancy of PTPN3 with PTPN4, we
generated PTPN4-deficient and PTPN4/PTPN3 double-deficient mice. As in PTPN3 mutants, T cell development and
homeostasis and TCR-induced cytokine synthesis and proliferation were found to be normal in PTPN4-deficient and PTPN4/
PTPN3 double-deficient mice. PTPN13 is another FERM and PDZ domain-containing non-receptor PTP that is distantly-
related to PTPN3 and PTPN4 and which has been shown to function as a negative-regulator of T helper-1 (Th1) and Th2
differentiation. Therefore, to determine if PTPN13 might compensate for the loss of PTPN3 and PTPN4 in T cells, we
generated mice that lack functional forms of all three PTP. T cells from triple-mutant mice developed normally and showed
normal cytokine secretion and proliferative responses to TCR stimulation. Furthermore, T cell differentiation along the Th1,
Th2 and Th17 lineages was largely unaffected in triple-mutants. We conclude that PTPN3 and PTPN4 are dispensable for TCR
signal transduction.
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Introduction
A common event in cellular signal transduction is the
phosphorylation of proteins on tyrosine residues which results in
diverse cellular outcomes. This phosphorylation is mediated by
protein tyrosine kinases (PTK). By contrast, protein tyrosine
phosphatases (PTP) remove phosphate groups from protein tyrosyl
residues and thus oppose the actions of PTK. The mammalian
genome encodes 38 classical PTP that can be subdivided into
receptor-like and non-transmembrane PTP [1–3]. The non-
transmembrane PTP family consists of 17 members, of which 14
are expressed in T lymphocytes of the immune system [4].
T cells become activated subsequent to MHC-peptide recogni-
tion mediated by the clonally distributed, cell surface expressed T
cell antigen receptor (TCR) [5]. One of the first events in the now
well-established TCR signaling cascade is the phosphorylation and
activation of the Src-family PTK, LCK and FYN [6]. These PTK
phosphorylate immunoreceptor tyrosine-based activation motifs
(ITAMs) present within the cytoplasmic tails of invariant CD3 and
TCRf proteins that form part of the TCR complex [7].
Subsequently, the Syk-family kinase, ZAP-70, is recruited to the
complex by the recognition of phosphorylated ITAMs, and, in
turn, is activated via Src-family PTK-mediated phosphorylation.
Activated ZAP-70 phosphorylates the transmembrane adapter
protein, linker for activation of T cells (LAT) [8]. LAT further
propagates the signal, leading to membrane recruitment of
additional signaling intermediates that ultimately result in the
nuclear mobilization of the transcription factors NFAT, NF-kB,
and AP-1 [9]. These transcription factors drive the expression of
new genes that result in cytokine secretion, cytokine receptor
expression, cell division, and effector cell differentiation.
While the role of PTK in TCR signal transduction has been
extensively studied, the identity of PTP that negatively-regulate
this pathway is less clear. PTP that are established physiological
negative-regulators of proximal TCR signaling are SHP-1 and
PEP. These PTP dephosphorylate and inactivate LCK, FYN, and
ZAP-70 [10–12]. Other PTP that have been implicated in
negative regulation of TCR signal transduction are PTPN3 and
PTPN4 [13,14]. In mice, these PTP are 50% identical and 67%
homologous at the amino acid level. They consist of an NH2-
terminal FERM (Band 4.1, Ezrin, Radixin, and Moesin) domain, a
central PDZ (PSD-95, Dlg, ZO-1) domain, and a COOH-terminal
PTP domain. FERM and PDZ domains bind the cytosolic domain
of transmembrane proteins [15–17]. Both domains have also been
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shown to bind directly to the phospholipid phosphatidylinositol 4,5
biphosphate (PIP2) [18,19]. The FERM domains of PTPN3 and
PTPN4 are required for PTP membrane localization in T cells
[20]. A screen in the Jurkat T cell leukemia line seeking to identify
candidate negative regulators of TCR signal transduction revealed
that over-expression of PTPN3 and PTPN4 resulted in an
approximate 75% and 40% reduction, respectively, of TCR-
induced activation of the promoter for the T cell growth-
promoting cytokine, IL-2 [21]. Mutation of the catalytic cysteine
residue or deletion of the FERM domain from these PTP
abrogated this inhibitory effect, illustrating the importance of
these domains for negative regulation [20,21]. In a separate study,
PTPN3 was shown to both bind and dephosphorylate TCRf in
vitro and when over-expressed in COS fibroblasts [22]. Recently,
PTPN4 has also been shown to dephosphorylate TCRf [23].
The third member of the FERM and PDZ domain-containing
PTP family is PTPN13, also known as PTP-Bas, PTP-BL, and
FAP-1 [24]. PTPN13 is a large protein that in addition to a PTP
domain contains one FERM domain, five PDZ domains and a
non-catalytic C-lobe domain. Mice that express a PTP domain-
deleted form of PTPN13 exhibit impaired motor nerve repair and
axon branching, and retinal ganglion cell neurite initiation and
survival [25,26]. This suggests a role for PTPN13 in neural cell
growth and survival, especially following injury. Additionally, in
vitro, T cells from PTPN13-deficient mice demonstrated increased
differentiation into T helper-1 (Th1) and T helper-2 (Th2) subsets
that synthesize the cytokines interferon-c (IFN-c) and IL-4
respectively [27]. Ostensibly, this is associated with increased
phosphorylation of signal transducer and activator of transcription
(STAT) proteins which mediate cytokine signal transduction.
We have previously shown that mice lacking PTPN3 exhibit
normal T cell development and function [28]. We hypothesized
that the lack of apparent function of PTPN3 in T cells can be
explained on the grounds that PTPN4 can substitute for the
function of PTPN3 in this cell type. To address this we have
generated PTPN4-deficient mice and PTPN4/PTPN3 double-
deficient mice. Furthermore, to address the possibility that
PTPN13 can substitute for the function of both PTPN4 and
PTPN3 in T cells, we have additionally generated PTPN4/
PTPN3/PTPN13 triple-mutant mice. The function of T cells in
these different mice has been examined.
Materials and Methods
Mice
The embryonic stem (ES) cell line, OST146128 (of 129 Sv/Ev
origin), which contains a gene trap cassette within intron 2 of the
ptpn4 locus, was purchased from Lexicon Genetics (The Wood-
lands, TX). ES cells were injected into C57BL/6J6(C57BL/
6J6DBA/2) blastocysts to generate chimeras, which were bred to
C57BL/6 mice to achieve germline transmission of the trapped
ptpn4 allele. F1 progeny were then intercrossed to generate
PTPN4-deficient mice for experiments. To generate PTPN4/
PTPN3 double-deficient mice, PTPN4 F1 mice were crossed to
ptpn3 tm1PdK/tm1PdK mice (C57BL/6 background) described previ-
ously [28]. Resulting PTPN4/PTPN3 double heterozygotes were
then intercrossed to generate double-deficient animals for
experiments, or were crossed to ptpn13 DPTP/DPTP (C57BL/6
background) mice also described previously [25]. In the latter case,
progeny were intercrossed twice to concentrate the targeted alleles,
and then intercrossed again to generate PTPN4/PTPN3-deficient
PTPN13 DPTP/DPTP triple-mutant mice. Unless otherwise
noted, all mice were 6–8 weeks of age at the time of
experimentation. All experiments were performed in compliance
with University of Michigan guidelines and were approved by the
University Committee on the Use and Care of Animals.
PCR
To confirm loss of PTPN4 expression in PTPN4 gene-trapped
mice, RNA was purified from splenocytes using Trizol (Invitrogen)
and analyzed by RT-PCR (Superscript One-Step kit; Invitrogen)
using a forward primer based in exon 2 and a reverse primer based
in exon 8 of the ptpn4 gene. bActin transcripts were also amplified
to control for the quantity and quality of RNA preparations.
Relative expression levels of PTPN4 in different tissues of wild-
type mice were determined by quantitative PCR of cDNA samples
from a Tissue Scan RT kit (Origene). Amounts of cDNA used in
reactions were normalized to expression levels of GAPDH in each
tissue. SYBR Green mastermix (Eurogentec) was used with a
forward primer based in exon 2 and a reverse primer based in
exon 3 of the ptpn4 gene and reactions were performed in an
MX3000p quantitative real-time PCR machine (Stratagene).
Cycle threshold values were used to calculate the relative
abundance of PTPN4 transcripts in tissues. Results were
normalized to the amount of PTPN4 transcript detected in
muscle, which was arbitrarily given a value of one.
Flow cytometry
Thymocytes, splenocytes, and lymph node (LN) cells were
blocked with murine IgG (Sigma) and stained with the following
conjugated monoclonal antibodies (BD Biosciences): H57-597-
APC (TCRb chain), RA3-6B2-APC-Cy7 (CD45R/B220), IM7-
FITC (CD44), GK1.5-APC-Cy7 (CD4), 53-6.7-PerCP (CD8) and
PC61-PE (CD25). Cell staining was analyzed by flow cytometry
using a FACSCanto (Becton Dickinson).
T cell cytokine synthesis and proliferation
LN cells were stimulated with varying concentrations of 145-
2C11 (CD3e; eBioscience) and 37.51 (CD28; BD Biosciences) in
96 well round-bottom plates in complete medium (RPMI
supplemented with 10% FCS, 25 nM b-mercaptoethanol, 50 U/
mL Penicillin, 50 mg/mL Streptomycin, 2 mM L-glutamine,
10 mM HEPES, and 1 mM sodium pyruvate). Concentrations
of cytokines in supernatants were determined by ELISA after 24 h
(IL-2) or 48 h (IFN-c and IL-4) of culture. To assess T cell
proliferation, splenocyte cultures were first labeled with 1 mM
carboxyfluorescein succinimidyl ester (CFSE; Molecular Probes),
and stimulated as above. After 72 h stimulation, CFSE fluores-
cence intensity was analyzed by flow cytometry.
In some experiments T cells were induced to differentiate into
Th1, Th2, or Th17 cells. For this purpose, splenic CD4+ T cells
were purified by negative selection and were stimulated with
immobilized anti-CD3 (3 mg/mL for coating) and soluble (1 mg/
mL) anti-CD28 antibodies plus recombinant human IL-2 (50 U/
mL) in complete medium. For Th1 and Th2 and differentiation,
IL-12 (3.5 ng/mL)/anti-IL-4 antibody (11B11; 10 mg/mL) or IL-4
(10 ng/mL)/anti-IFN-c antibody (R4-6A2; 10 mg/mL), respec-
tively, were added to the cultures. To induce Th17 cell
differentiation, anti-IFN-c (10 mg/mL), anti-IL-4 (10 mg/mL),
IL-23 (20 ng/mL), IL-6 (10 ng/mL), and TGFb (5 ng/mL) were
added to media. After 72 h, cells were recultured in complete
medium supplemented with IL-2 for Th1 and Th2 polarized
cultures or anti-IL-4/anti-IFN-c/IL-23/IL-6 for Th17 polarized
cultures as above. After a further 48 h, cells were restimulated with
immobilized CD3 antibody (1 mg/mL for coating), and superna-
tants were harvested after 24 h for quantitation of cytokine
secretion by ELISA. All cytokines and blocking antibodies were
purchased from PeproTech and BD Biosciences, respectively.
PTPN3/4/13 and TCR Signaling
PLoS ONE | www.plosone.org 2 December 2008 | Volume 3 | Issue 12 | e4014
Figure 1. Generation of PTPN4-deficient mice. A) Relative PTPN4 expression levels were determined by quantitative PCR of different tissue
cDNA samples using PTPN4-specific primers. For each tissue, expression levels are normalized to muscle, arbitrarily given a value of 1. N.D., not
detected. B) Top, Domain organization of PTPN4, showing the location of the FERM, PDZ, and PTP domains. Bottom, Exon/intron organization of the
59 end of the ptpn4 gene encoding part of the PTPN4 FERM domain. The location of the gene-trapping cassette within intron 2 is shown. Note that
exon 2 contains the translation initiation site. Arrows indicate positions of PCR primers used in panel C. SA, splice acceptor; Neo, sequence encoding
neomycin phosphotransferase; pA, polyadenylation sequence; PGK, cloning vector component of gene trap. C) RTPCR was performed upon RNA
isolated from splenocytes from mice heterozygous and homozygous for the gene-trapped allele using PTPN4 primers shown in B or control b-actin-
primers. Note the complete absence of PTPN4 transcripts in the homozygous mice.
doi:10.1371/journal.pone.0004014.g001
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Statistical analysis
Statistical significance of differences in cell population repre-
sentation or in cytokine secretion between test and control mice
was assessed using a paired or unpaired Student’s T-test as
indicated.
In T cell polarization studies, in order to compile data from a
number of independent experiments, cytokine secretion by
different PTP mutant T cells was first normalized to that observed
with control T cells to derive a fold increase in cytokine secretion
as follows: (PTP mutant secretion–control secretion)/control
secretion (in the case of increased secretion by mutant; assigned
a positive value) or (control secretion–PTP mutant secretion)/PTP
mutant secretion (in the case of decreased secretion by mutant;
assigned a negative value). Mean fold increase in cytokine
secretion relative to wild-type secretion was then calculated for
several repeat experiments. Statistical significance of differences in
cytokine secretion between PTP mutant and control cells was
determined with the use of a paired Students T-test.
Western blotting
Splenocytes were lysed in a buffer containing 1% NP-40, run on
SDS-PAGE gels and transferred to PVDF membranes (Perkin
Elmer). Membranes were then probed with an anti-PTPN3 mAb
[28], before stripping and reprobing with a GAPDH antibody (FL-
335; Santa Cruz) to determine the amount of total protein loaded
in each lane.
Results
Generation of PTPN4-deficient mice
PTPN4 is a member of the non-transmembrane PTP family
that contains both a FERM and PDZ domain. A previous report
had indicated that PTPN4 is strongly expressed in testis [29]. To
analyze which other tissues also expressed PTPN4, we performed
quantitative PCR upon a panel of normalized mouse tissue cDNA
samples using PTPN4-specific primers (Figure 1A). As shown,
PTPN4 transcript levels were indeed highest in male reproductive
Figure 2. Normal T cell development and function in PTPN4-deficient mice. A) Flow cytometry plots of thymocytes, LN cells, and
splenocytes from PTPN4-deficient mice and littermate controls showing expression of the indicated markers on live cell populations. Percentages of
cells that fall within the indicated regions are shown. Data are representative of three repeat experiments. B) LN T cells were stimulated with the
indicated concentrations of CD3 antibody and 0.5 mg/mL CD28 antibody. Concentrations of cytokines in supernatants were determined by ELISA.
Each symbol represents the mean of triplicate determinations from a single mouse. Bars represent the mean cytokine secretion. Differences between
PTPN4-deficient and control mice are not statistically significant (Paired Student’s T test).
doi:10.1371/journal.pone.0004014.g002
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organs. In addition, however, PTPN4 was also expressed in most
other examined tissues including thymus and spleen.
To study the role of PTPN4 in T cells, we generated PTPN4-
deficient mice. For this purpose, we obtained an ES cell line that
contained a gene trap inserted within the ptpn4 locus. This ES cell
line was used to generate chimeric founder mice which were
crossed to wild-type mice to achieve germline transmission of the
trapped allele. Heterozygote PTPN4 mice were then intercrossed
to generate homozygous PTPN4 mutants. Homozygote mutants
were born in the expected Mendelian ratios and displayed no
abnormalities in growth or development. Both male and female
mice were fertile.
The PTPN4 gene trap is contained within intron 2 of the ptpn4
locus, downstream of exon 2 that contains the translation initiation
codon (Figure 1B). Consequently, in primary transcripts produced
from the gene-trapped allele, exon 2 would be spliced to the gene
trap which contains a strong splice acceptor at its 59end. This
would result in extinction of PTPN4 protein expression since read
through of exon 2 to exon 3 would not occur. To confirm loss of
PTPN4 expression, we performed RTPCR upon splenic RNA
from heterozygote and homozygote gene-trapped mice using a
forward primer based in exon 2 and a reverse primer based in
exon 8 of the ptpn4 gene (Figure 1C). As shown, PTPN4 amplicons
of the expected size were readily detected in heterozygote mice but
were completely absent from homozygote mice. Thus, homozy-
gous PTPN4 gene-trapped mice are PTPN4 null and cannot
express PTPN4 protein.
Intact immune compartments in PTPN4-deficient mice
In order to investigate a potential role for PTPN4 in immune
cell development, we examined the numbers and ratios of
leukocytes in primary and secondary lymphoid organs of
PTPN4-deficient mice by flow cytometry (Figure 2A). With
regards T cell development in the thymus, no differences were
observed in the number or ratio of CD42CD82 double-negative
(DN), CD4+CD8+ double-positive (DP) or CD4+CD82 or
CD42CD8+ single-positive (SP) thymocytes compared to con-
trols. Likewise, no differences in the number or ratio of CD4+ or
CD8+ T cells were observed in LN or spleen. All other examined
leukocytic populations including B cells, macrophages, dendritic
cells, granulocytes and NK cells were also normally represented in
secondary lymphoid organs as well as bone marrow of PTPN4-
deficient mice (Figure 2A and not shown).
T cell activation and function in PTPN4-deficient mice
We next examined the ability of PTPN4-deficient T cells to
synthesize cytokines in response to TCR stimulation. LN cells
from PTPN4-deficient and control mice were thus stimulated with
Figure 3. PTPN4/PTPN3 double-deficient mice show normal T cell development. A) Expression of PTPN4 in mice of the indicated
genotypes (top) determined by RTPCR. B) Expression of PTPN3 in mice of the indicated genotypes (top) determined by Western blotting. Blots were
stripped and reprobed with GAPDH antibodies to confirm equivalent protein loading. C) Flow cytometry plots of thymocytes and peripheral immune
cells from PTPN42/2PTPN32/2mice and littermate controls showing expression of the indicated markers on live cell populations. In CD44/CD62L
plots, the gated population represents recently activated memory T cells. Data are representative of six repeat experiments.
doi:10.1371/journal.pone.0004014.g003
Figure 4. T cell cytokine synthesis and proliferation in PTPN4/PTPN3 double-deficient mice. A) LN T cells were stimulated with the
indicated concentrations of CD3 antibody and 0.75 mg/mL CD28 antibody. Concentrations of cytokines in supernatants were determined as in
Figure 2. Each bar represents the mean plus one standard deviation of triplicate determinations from one mouse. Differences between mice are not
statistically significant (Student’s T-test). Data are representative of six repeat experiments. B) Splenic T cells were labeled with CFSE and stimulated
with 0.1 mg/mL CD3 antibody and 0.75 mg/mL CD28 antibody. After 72 h, CFSE dye intensity was measured by flow cytometry. The percentage of live
cells that have undergone the indicated number of cell divisions is shown. Data are representative of three repeat experiments.
doi:10.1371/journal.pone.0004014.g004
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CD3 antibodies (directed to the TCR complex) and antibodies
against the CD28 T cell costimulatory receptor. Secretion of
cytokines into culture supernatants was then measured by ELISA.
No significant differences in the synthesis of the T cell growth
factor, IL-2, or the hallmark Th1 and Th2 cytokines, IFN-c and
IL-4, respectively, were apparent in these experiments (Figure 2B
and data not shown). Thus, PTPN4 appears to be dispensable for
TCR-induced synthesis of these cytokines.
T cell development and function in PTPN4/PTPN3
double-deficient mice
We hypothesized that the apparent lack of a T cell phenotype in
PTPN4-deficient mice can be explained by a functional redundancy
of PTPN4 with PTPN3 and vice versa. Analysis of the expression of
PTPN3 in PTPN4-deficient mice and of PTPN4 in PTPN3-
deficient mice indicated that loss of expression of one PTP did not
result in a compensatory increase in expression of the other PTP
(Figure 3 A and B). Nonetheless, the possibility of functional
redundancy still existed. Therefore, PTPN4-deficient mice were
crossed with PTPN3-deficient mice and progeny were then
intercrossed to generate PTPN4/PTPN3 double-deficient mutants.
Like single PTP-deficient mice, PTPN4/PTPN3-double-defi-
cient mice were born in expected Mendelian ratios and showed
normal growth and development. With regards T cell develop-
ment, no abnormalities were apparent (Figure 3C). Numbers and
ratios of DN, DP and SP thymocyte subpopulations were normal
and among DN cells, the representation of CD44+CD252 (DN1),
CD44+CD25+ (DN2), CD44loCD25+ (DN3) and
CD442CD252 (DN4) subsets was unaffected in the double-
mutants. Similarly, in secondary lymphoid organs, numbers and
ratios of CD4+ and CD8+ T cells were normal. In addition, there
was no evidence of any increased previous or ongoing T cell
activation as judged by an increase in the frequency of cells that
express the CD44 memory cell marker or a decrease in the
frequency of cells that express CD62L, respectively.
To examine the influence of loss of expression of PTPN4 and
PTPN3 upon T cell function, we examined both T cell cytokine
synthesis and T cell proliferation in PTPN4/PTPN3 double-
deficient mice. Synthesis of IL-2, IFN-c and IL-4 in response to
CD3/CD28 antibody stimulation was determined as before
(Figure 4A). As shown, T cells from PTPN4/PTPN3 double-
deficient mice secreted similar quantities of these cytokines in these
assays as T cells from control mice. To assess division, T cells were
labeled with CFSE and dilution of CFSE was determined 72 h
post-CD3/CD28 stimulation (Figure 4B). These analyses revealed
that PTPN4/PTPN3 double-deficient T cells proliferate compa-
rably to control T cells in vitro.
Generation and characterization of PTPN4/PTPN3
double-deficient PTPN13 DPTP/DPTP mice
The remaining PTP in the mouse and human genomes that
contains both FERM and PDZ domains is PTPN13. Although the
degree of homology between PTPN13 and PTPN4 or PTPN3 is
much less than that between PTPN4 and PTPN3, the possibility
that PTPN13 might compensate functionally for the loss of
PTPN4 and PTPN3 in T cells existed. Moreover, recent studies of
PTPN13-deficient mice indicated that this PTP regulates T helper
cell differentiation through function as a negative-regulator of the
phosphorylation of STAT-4 and STAT-6. Therefore, we asked if a
role for PTPN4 and PTPN3 in T cells might be revealed in mice
that do not express functional PTPN13. To examine this, PTPN4/
PTPN3 double-deficient mice were crossed with mice that express
a PTP domain-deleted PTPN13 protein (PTPN13 DPTP) to
generate PTPN4/PTPN3-double-deficient PTPN13 DPTP/DPTP
mutant mice [25]. As with single PTP and PTP double-deficient
mutants, PTPN4/PTPN3 double-deficient PTPN13 DPTP/DPTP
mice were born in normal Mendelian ratios and showed normal
growth and development. With regards T cell development,
analysis of the numbers and ratios of T cell subsets in thymus and
peripheral lymphoid organs showed that this was also normal in
triple-mutant mice (Figure 5). In addition, peripheral T cells from
triple-mutants were found to secrete similar amounts of cytokines
and proliferated to the same extent in response to CD3/CD28-
stimulation as T cells from control mice (Figure 6).
Given the reported role of PTPN13 in control of T helper cell
differentiation, we examined this directly in the triple-mutants. T
cells from wild-type, PTPN13 DPTP/DPTP, PTPN4/PTPN3
double-deficient, and PTPN4/PTPN3 double-deficient PTPN13
DPTP/DPTP mice were thus induced to differentiate along Th1,
Th2 or Th17 lineages (see Materials and Methods). To examine
the extent of differentiation, cells were then re-stimulated with
CD3 antibody and secretion of IFN-c, IL-4 and IL-17,
respectively, was determined by ELISA (Figure 7). Results of
these analyses showed that T cells from PTPN3/PTPN4-double-
deficient mice were able to differentiate along the Th1, Th2 and
Th17 lineages to an extent comparable to that observed with T
cells from wild-type mice. Similarly, T cells from PTPN13 DPTP/
DPTP mice showed the same extent of differentiation into Th1
Figure 5. Normal T cell development in PTPN4/PTPN3 double-
deficient PTPN13 DPTP/DPTP mice. Thymocytes and splenocytes
from mice of the indicated genotypes were analyzed by flow cytometry
for expression of T cell and B cell markers. Shown is the mean
percentage representation plus one standard deviation of the indicated
subpopulations among total live cells (n = 4 mice of each genotype).
Differences between mice are not statistically significant.
doi:10.1371/journal.pone.0004014.g005
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and Th17 cells as T cells from wild-type mice, although showed
increased differentiation along the Th2 cell lineage. These last
results, therefore, differ from previous findings where increased
Th1 differentiation as well as increased Th2 differentiation was
reported in PTPN13-deficient mice. Finally, and importantly, T
cells from PTPN4/PTPN3 double-deficient PTPN13 DPTP/
DPTP mice behaved similarly to T cells from PTPN13 DPTP/
DPTP mice in so much that they showed normal differentiation
into Th1 and Th17 cells and somewhat increased differentiation
along the Th2 lineage (albeit not reaching statistical significance,
p,0.07). In summary, these results show that PTPN3 and PTPN4
are dispensable for T cell function, even in the absence of
functional PTPN13.
Discussion
The non-receptor PTP, SHP-1 and PEP, are established
physiological negative-regulators of TCR signal transduction that
act by dephosphorylating PTK that become activated at an early
point in the TCR signaling cascade [10–12]. However, the identity
of PTP which dephosphorylate other tyrosine-phosphorylated
proteins in this cascade, and which may thus also function as
negative-regulators of TCR signaling, has remained elusive. In this
regard, there has been considerable interest in two closely related
PTP, PTPN3 and PTPN4, as potential novel negative-regulators
of TCR signal transduction. Both PTP are able to dephosphor-
ylate the TCRf chain in vitro and in cell lines [22,23]. In addition,
when over-expressed in the Jurkat T leukemia cell line, both PTP
inhibit TCR-induced activation of the IL-2 promoter, an effect
that requires an intact FERM domain necessary for translocation
of these PTP to the plasma membrane [20,21].
To address if PTPN3 functions as a physiological negative-
regulator of TCR signal transduction, we recently generated
PTPN3-deficient mice [28]. However, no abnormalities in T cell
development or function were apparent in these mice. We
hypothesized that the lack of a T cell phenotype could be
explained by a functional redundancy of PTPN3 with PTPN4,
since both PTP are expressed in T cells. Hence, in the current
study, we generated PTPN4-deficient and PTPN3/PTPN4
double-deficient mice. Consistent with a recent report, T cell
development and function was found to be normal in PTPN4-
deficient mice [23]. Moreover, there was no apparent T cell
Figure 6. Function of PTPN4/PTPN3 double-deficient PTPN13 DPTP/DPTP T cells. A) LN T cells were stimulated with the indicated
concentrations of CD3 antibody and 0.5 mg/mL CD28 antibody. Concentrations of cytokines in supernatants were determined as in Figure 2.
Differences between mice are not statistically significant, excepting IFN-c secretion at low dose anti-CD3 which is not a reproducible finding over four
repeat experiments. B) Splenic T cells were labeled with CFSE and stimulated with 0.1 mg/mL CD3 antibody and 0.5 mg/mL CD28 antibody. After
72 h, CFSE dye intensity was measured by flow cytometry. Data are representative of four mice of each genotype.
doi:10.1371/journal.pone.0004014.g006
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phenotype in PTPN3/PTPN4 double-deficient mice either. Thus,
PTPN4 does not compensate for the loss of PTPN3 in T cells and
vice versa.
We further asked if the absence of a T cell phenotype in
PTPN3/PTPN4 double-deficient mice could be explained by
functional redundancy with PTPN13, which also contains FERM
and PDZ domains, albeit that this PTP shows a low degree of
homology to PTPN3 and PTPN4. Therefore, we generated
PTPN4/PTPN3 double-deficient PTPN13 DPTP/DPTP mice
that lack functional forms of all three PTP. Once again, T cell
development and TCR-induced cytokine secretion and prolifer-
ation were found to be normal in these mice. In addition, since
PTPN13 has previously been shown to inhibit Th1 and Th2
differentiation through dephosphorylation of STAT proteins, we
examined T helper cell polarization in triple-mutants [27]. In
comparison to T cells from control mice, T cells from triple-
mutant mice showed normal differentiation into Th1 and Th17
cells. An increased (not statistically significant) propensity of T cells
Figure 7. PTPN4 and PTPN3 are not required for CD4+ T cell differentiation. Purified CD4+ T cells were cultured under Th1-, Th2-, or Th17-
inducing conditions. T cells were re-stimulated with CD3 antibodies and concentrations of IFN-c, IL-4, and IL-17, respectively, in culture supernatants
was determined by ELISA. A) Shown are results of a representative Th1/Th2 polarization experiment comparing control, PTPN13 DPTP/DPTP and
PTPN4/PTPN3 double-deficient PTPN13 DPTP/DPTP T cells. Shown is mean cytokine secretion plus 1 standard deviation of triplicate determinations
from single littermate mice. Conditions of polarization are indicated on the x-axis. B) Several repeat experiments of the type indicated in A) were
performed. In each experiment, a fold increase in IFN-c, IL-4 or IL-17 expression under conditions of Th1, Th2 or Th17 polarization respectively was
calculated for mutant T cells relative to wild-type T cells (see Materials and Methods). Shown is the mean fold increase+/2one standard error
(PTPN42/2PTPN32/2PTPN13+/DPTP, n = 8; PTPN4+/2PTPN3+/2PTPN13 DPTP/DPTP, n = 5; PTPN42/2PTPN32/2PTPN13 DPTP/DPTP, n = 4). note
that a 0 value fold increase indicates no change in cytokine secretion relative to wild-type. * differences relative to wild-type responses are statistically
significant as determined in a paired Student’s T-test comparing raw data (see Materials and Methods). All other differences relative to wild-type cells
are not statistically significant. # p,0.07.
doi:10.1371/journal.pone.0004014.g007
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to differentiate into Th2 cells was observed in triple-mutants.
However, this increased Th2 differentiation was no greater in
magnitude than that observed with PTPN13 DPTP/DPTP T cells.
Thus, in conclusion, we have found no evidence for the notion that
PTPN3 and PTPN4 function as negative-regulators of TCR signal
transduction.
Functions for PTPN3 and PTPN4 outside of the immune system
have been proposed. PTPN3 has been shown to dephosphorylate the
growth hormone receptor (GHR) and one other group reported an
increased weight gain amongst male PTPN3-deficient mice [30,31].
These findings suggest a role for PTPN3 as a negative-regulator of
GHR signal transduction and body mass. However, counter to this,
in our colony, we have not observed any increased growth of male or
female PTPN3-deficient mice up to 18 months of age. Similarly, we
have not observed any increased body mass of PTPN4-deficient or
PTPN4/PTPN3 double-deficient mice in comparison with littermate
controls (not shown). It is possible that this discrepancy can be
explained in terms of differences in genetic background or the precise
nature of genetic disruptions in PTPN3 mutant strains. With regards
strain differences, PTPN3 mutant mice that we have studied include
PTPN3 gene-trapped mice on a 129P2/Ola Hsd background and
PTPN3 gene-targetedmice on a C57BL/6 background (neither show
growth abnormalities) [28]. By contrast, in the study in which an
increased weight gain was reported for PTPN3-deficient males, mice
were on a mixed 129 SvEv6C57BL/6 genetic background [31].
Concerning differences in the precise nature of disruptions, of the two
PTPN3 mutant mice that were generated in our laboratory, we
established by Western blotting that expression of PTPN3 protein
was extinguished. By contrast, in the third PTPN3 mutant strain,
although the nature of the genetic mutation precludes expression of
catalytically-active PTPN3 protein, whether or not these mice express
truncated forms of PTPN3 that contain only modular binding
domains remains to be established.
Aside from growth, PTPN3 and PTPN4 have both been
ascribed functions within the central nervous system. PTPN4
interacts with glutamate receptor subunits, which are required for
neural development and function [32]. Consistent with a neural
role, PTPN4-deficient mice were shown to have impaired
cerebellar function, including defective motor learning [33]. In a
recent report, PTPN3-deficient mice were also shown to have
impaired memory function and motor learning, albeit that
significant differences compared to controls were detected only
in females [34]. Furthermore, in Drosophila, loss of expression of
PTPMEG (the single homologue of PTPN3 and PTPN4 in this
species) results in defective axon growth associated with impaired
development of mushroom bodies [35]. Therefore, given these
reports, we examined motor learning function in our own PTPN4
and PTPN3 single-deficient mice and in PTPN4/PTPN3 double-
deficient mice. In an accelerated rotarod test, no difference in
motor learning was noted in comparison with controls (not shown).
For PTPN3, discrepancies might again be explained by differences
in background strain or the precise nature of genetic disruptions.
For PTPN4, only strain differences could be invoked to account
for the discrepant findings. Thus, the PTPN4-deficient mice
reported here are on a mixed 129 SvEv6C57BL/6 background
whereas the PTPN4-deficient mice that were reported to exhibit
motor learning defects are on a 129SvJ background [33]. In both
types of PTPN4 mutant, although the precise nature of the genetic
mutation differs, PTPN4 gene expression was shown to be
extinguished.
In summary, we have thus far been unable to observe any
phenotypic abnormalities in PTPN4-deficient, PTPN3-deficient or
PTPN4/PTPN3 double-deficient mice either within or without
the immune system. Thus, a physiological function for these PTP,
that can be consistently demonstrated, awaits discovery. In
considering potential other roles, it is of interest that human
papillomaviruses specifically target FERM and PDZ domain-
containing PTP for degradation during infection and transforma-
tion [36–38]. One possible explanation for this finding is that
FERM and PDZ domain-containing PTP play a role in defense
against this type of virus. Notwithstanding the fact that human
papillomaviruses do not infect murine cells, discovery of the
function of these PTP in papillomavirus infection could provide
important clues as to their role in normal cellular physiology.
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